Apple: More Questions Than Answers

Apple investors expecting details about the Steve Jobs health saga left the firm's shareholder meeting disappointed Wednesday.

Pressed for information about Jobs' condition, the iPhone maker said its CEO is still deeply involved in the firm's strategy but did not offer specifics about his health, according to CNNMoney.

After gaining 91 cents, or just over 1%, to close at $91.16 Wednesday, Apple's shares fell 8 cents in extended trading.

Jobs, who is on a five-month medical leave of absence, did not attend the event in Cupertino, Calif., missing his first shareholders' meeting in a decade.

The talismanic CEO, who fought pancreatic cancer in 2004 and announced recently that he is suffering from a hormone imbalance earlier this year, is widely credited with creating the Apple phenomenon, making his absence all the more notable.

With Apple's COO Tim Cook overseeing day-to-day operations since his boss's departure in January, shareholders were also looking for more color on the firm's succession plans.

Genentech(DNA) CEO and Apple board member Arthur Levinson sought to reassure shareholders but gave little away, according to CNNMoney.

"Nothing has changed," he said. "Succession planning is something this board takes up regularly -- you can assume we will do that responsibly."

Another hot topic at the meeting, which was not Webcast, was the manner in which Apple has disclosed information regarding Jobs' health.

Levinson defended the company's actions and said it released information in an appropriate fashion. "We believe we have met all disclosure obligations," he said.